Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Julia Bluhm"'
Autor:
Mario Bunse, Janina Pfeilschifter, Julia Bluhm, Maria Zschummel, Jara J. Joedicke, Anthea Wirges, Helen Stark, Vivien Kretschmer, Markus Chmielewski, Wolfgang Uckert, Hinrich Abken, Jörg Westermann, Armin Rehm, Uta E. Höpken
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-19 (2021)
CAR-T cell therapy targeting CD19 is not as efficient to treat lymphoma with nodal dissemination as it is for B cell leukaemia. Here, the authors generate CAR-T cells against CXCR5 and show they inhibit tumour growth by depleting both B and follicula
Externí odkaz:
https://doaj.org/article/ec898a29a91e4a4fa35537b32be47016
Publikováno v:
Human Genomics, Vol 14, Iss 1, Pp 1-15 (2020)
Abstract Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting the central nervous system in young adults. Heparan sulfate proteoglycans (HSPGs) are ubiquitous to the cell surface and the extracellular matrix. HSPG biosynt
Externí odkaz:
https://doaj.org/article/ee91755591454b90bdd5d72d47753f55
Autor:
Ronald Simon, Thomas Blankenstein, Jennifer Oduro, Natalia Gorbokon, Christoph Fraune, Julia Bluhm, Vivian Scheuplein, Elisa Kieback, Matthias Obenaus, Eugen Leo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ba13c44bf5c24d86a2ab8e2c4ce320de
Publikováno v:
Current opinion in immunology. 74
The focus in cancer immunotherapy has mainly been on CD8 T cells, as they can directly recognize cancer cells. CD4 T cells have largely been neglected, because most cancers lack MHC II expression and cannot directly be recognized by CD4 T cells. Yet,
Publikováno v:
Human Genomics
Human Genomics, Vol 14, Iss 1, Pp 1-15 (2020)
Human Genomics, Vol 14, Iss 1, Pp 1-15 (2020)
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting the central nervous system in young adults. Heparan sulfate proteoglycans (HSPGs) are ubiquitous to the cell surface and the extracellular matrix. HSPG biosynthesis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1f47d4a6c160b0c90085f45e5107eb
https://doi.org/10.21203/rs.2.23090/v1
https://doi.org/10.21203/rs.2.23090/v1
Autor:
Uta E. Höpken, Wolfgang Uckert, Julia Bluhm, Stephen F. Marino, Hinrich Abken, Felix Oden, Jörg Westermann, Elisa Kieback, Markus Chmielewski, Armin Rehm
Autologous T cells genetically modified with a chimeric antigen receptor (CAR) redirected at CD19 have potent activity in the treatment of B cell leukemia and B cell non-Hodgkin’s lymphoma (B-NHL). Immunotherapies to treat multiple myeloma (MM) tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89baaf38e84c88a10b5cbf9f0a275842
https://europepmc.org/articles/PMC6094395/
https://europepmc.org/articles/PMC6094395/
Autor:
Andreas A. Werdich, Hans-Heiner Kramer, Paul J.R. Barton, Jörg-Detlef Drenckhahn, Christine Harnack, Sebastian Schafer, Janine Martitz, Julia Bluhm, Calum A. MacRae, Matthias Greutmann, Eva Klopocki, M. Khaled Sabeh, Almuth Caliebe, Norbert Hubner, Gabriel Musso, Anne-Karin Arndt, Sabine Klaassen, Matthias Heinig, Robert F. Padera, Hermann Kalwa, Felix Berger, Katharina Wassilew, Reiner Siebert, Eva Plovie, Stuart A. Cook
Publikováno v:
The American Journal of Human Genetics. (1):67-77
Deletion 1p36 syndrome is recognized as the most common terminal deletion syndrome. Here, we describe the loss of a gene within the deletion that is responsible for the cardiomyopathy associated with monosomy 1p36, and we confirm its role in nonsyndr